ArticlePloS one2019

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity.

Norman Fultang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.